Clinical Characteristics of Heart Disease Patients With a Good Prognosis in Spite of Markedly Increased Plasma Levels of Type-B Natriuretic Peptide (BNP): Anomalous Behavior of Plasma BNP in Hypertrophic Cardiomyopathy

Background Although it is not rare to encounter patients with plasma B-type natriuretic peptide (BNP) levels unequivalent to the severity of heart failure (HF), there has been little investigation to clarify the causative background of this phenomenon. Methods and Results Among the 1,838 outpatients...

Full description

Saved in:
Bibliographic Details
Published in:Circulation Journal 2005, Vol.69(3), pp.277-282
Main Authors: Takeuchi, Ichiro, Inomata, Takayuki, Nishii, Mototsugu, Koitabashi, Toshimi, Nakano, Hironari, Shinagawa, Hisahito, Takehana, Hitoshi, Izumi, Tohru
Format: Article
Language:English
Subjects:
Aged
Biomarkers - blood
Cardiomyopathy, Hypertrophic - blood
Cardiomyopathy, Hypertrophic - diagnosis
Electrocardiography
Female
Heart Diseases - blood
Heart Diseases - diagnosis
Heart failure
Humans
Hypertrophic cardiomyopathies
Male
Middle Aged
Natriuretic Peptide, Brain - blood
Natriuretic peptides
Norepinephrine - blood
Prognosis
Renin - blood
Severity of Illness Index
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Although it is not rare to encounter patients with plasma B-type natriuretic peptide (BNP) levels unequivalent to the severity of heart failure (HF), there has been little investigation to clarify the causative background of this phenomenon. Methods and Results Among the 1,838 outpatients whose plasma BNP was measured, persistently increased levels of BNP above 500 pg/ml was observed for more than 6 months in 14 subjects with few HF symptoms. Among these, all of 4 patients without any following cardiac events (E-/high) for 12 months showed hypertrophic nonobstructive cardiomyopathy (HNCM). When we compared the clinical parameters of these patients with those of 22 HNCM patients without any following cardiac events whose plasma BNP levels were less than 200 pg/ml, there were only 2 clinical characteristics to be distinguished: (i) plasma renin activity (PRA) and norepinephrine (NE) levels were low in spite of markedly increased levels of plasma BNP in E-/high HNCM; and (ii) echocardiographic investigation revealed that only global left atrial fractional shortening was significantly lower in E-/high HNCM. Conclusions Plasma BNP levels do not always reflect the severity of HF in HNCM. It might be considered to utilize other clinical parameters such as NE and PRA to recognize HF severity in such patients. (Circ J 2005; 69: 277 - 282)
ISSN:1346-9843
1347-4820
DOI:10.1253/circj.69.277